Stroke clinical trial finds intensive medical treatment better than brain stent
by Anil Kumar

Patients at a high risk for a second stroke who received intensive medical treatment had fewer strokes and deaths than patients who received a brain stent in addition to the medical treatment, a large nationwide clinical trial has shown.
NewYork-Presbyterian Hospital and its two academic affiliates -- Columbia University Medical Center and Weill Cornell Medical College -- were part of the Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
In total, 50 medical centers participated, led by the Medical University of South Carolina in Charleston.
According to the study authors, the SAMMPRIS results have immediate implications for clinical practice. Stroke patients with recent symptoms and intracranial arterial blockage of 70 percent or greater should be treated with aggressive medical therapy alone that follows the regimen used in this trial as closely as possible.
New enrollment in the study was stopped in April because early data showed significantly more strokes and deaths occurred among the stented patients at the 30-day mark compared with the group who received the medical management alone.
Half the patients in the study received a medical regimen that included daily anti-thrombotic medications and aggressive control of blood pressure and cholesterol. The other patients in the study received an intervention of a self-expanding stent that widens a major artery in the brain and facilitates blood flow.
One possible explanation for the higher stroke rate in the stented group is that patients who have had recent stroke symptoms sometimes have unstable plaque in their arteries that the stent could have dislodged, the study authors suggest.
The study device, the Gateway-Wingspan intracranial angioplasty and stenting system, is the only system currently approved by the U.S. Food and Drug Administration (FDA) for certain high-risk stroke patients.
The authors noted that although similar stenting systems that do not have FDA approval are being used in clinical practice, they did not evaluate those devices in this study.
The authors also emphasize that the study participants were in the highest risk category, with blockage or narrowing of arteries of 70 to 99 percent. Stroke patients with moderate cerebral arterial blockage (50 to 69 percent) were excluded because their risk of stroke is low with usual medical management, and researchers thought this group would be unlikely to benefit from stenting.
(Anil Kumar -- sub-editor compiled and published
Stroke clinical trial finds intensive medical treatment better than brain stent at HealthNewsTrack on September 8, 2011 sourced from Weill Cornell Medical College - http://www.med.cornell.edu/)
Stroke - recent articles and current news stories:
-
Stroke risk greater for older women with atrial fibrillation-
Citrus fruit may lower women's stroke risk-
Bariatric surgery reduces heart attack and stroke in obese-
Magnetic stimulation of brain may help stroke patients recover-
Smoking causes stroke to occur 10 years beforeMost related articles:
-
Stroke clinical trial finds intensive medical treatment better than brain stent-
Intensive blood glucose lowering treatment proved fatal for diabetes patients - 8
-
Prasugrel cuts risk of stent-related clots - 7.8
-
Stent design may put patients at risk of heart attack - 7.1
-
Drug eluting stents prove more effective - 6.9
More related articles:
- Stroke, Clinical trial, Brain, Stent, Brain stent, SAMMPRIS, Intracranial arterial blockage, Medical therapy
-
Stent design may put patients at risk of heart attack - 13.6
-
Prasugrel cuts risk of stent-related clots - 13.5
-
Drug eluting stents prove more effective - 11.1
-
Certain drug coated stents may be safe, effective - 10.8
Stroke related articles:
-
Second stroke often follows within hours of first - 4
-
Statins may help prevent stroke recurrence - 3.7
-
Chocolate may lower stroke risk - 3.6
-
Secondary stroke prevention needs improvement - 3.5
-
Use of clot busters for stroke increased from 2005 to 2009 - 3.3
Stroke article/news source:
Read more health articles from
Weill Cornell Medical College and
health articles from USA.
Stroke - search related terms:
Brain,
Brain stent,
Clinical trial,
Intracranial arterial blockage,
Medical therapy,
SAMMPRIS,
Stent,
Stroke,
Stroke books,
Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Current news
Intensive medical therapy more effective than stenting for preventing a second stroke -- Results of NIH-funded clinical trial published in New England Journal of Medicine
What is Stroke?About Stroke -- Strokes are classified as a group of brain disorders involving a loss of functions (neurologic deficits) that occur when the blood supply to any part of the brain is interrupted. Even a brief interruption to the circulation can cause decreases in brain function. The specific neurologic deficits may vary depending on the location, extent of the damage, and cause of the disorder. A stroke affects about 4 out of 1,000 people.